Tower Research Capital (TRC)’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$54.2K Sell
1,329
-603
-31% -$24.6K ﹤0.01% 3177
2026
Q2
$80.9K Buy
1,932
+455
+31% +$17.6K ﹤0.01% 2354
2026
Q1
$55.6K Buy
1,477
+93
+7% +$3.04K ﹤0.01% 2653
2025
Q4
$41.6K Buy
1,384
+300
+28% +$8.49K ﹤0.01% 2566
2025
Q3
$28.4K Sell
1,084
-392
-27% -$9.34K ﹤0.01% 2991
2025
Q2
$31.5K Buy
1,476
+917
+164% +$20.7K ﹤0.01% 3361
2025
Q1
$11.9K Buy
559
+69
+14% +$1.42K ﹤0.01% 3493
2024
Q4
$9.9K Buy
+490
New +$10.1K ﹤0.01% 3859

Other funds holding GRDN

Tower Research Capital (TRC)'s GRDN Position: Q3 2026 in Review

Tower Research Capital (TRC) reduced its Guardian Pharmacy Services (GRDN) stake by 31% in Q3 2026, selling an estimated $24.6K and leaving 1,329 shares worth $54.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3177.

Tower Research Capital (TRC) first reported a position in GRDN in Q4 2024 and has held it in 8 quarters since. The position peaked at $80.9K in Q2 2026. 197 funds tracked by Wall St. Rank hold GRDN as of Q3 2026.

  • Tower Research Capital (TRC) held 1,329 shares of Guardian Pharmacy Services worth $54.2K as of Q3 2026.
  • Tower Research Capital (TRC) sold 603 Guardian Pharmacy Services shares in Q3 2026, an estimated $24.6K.
  • Guardian Pharmacy Services made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #3177 holding.
  • Tower Research Capital (TRC) first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 8 quarters since.
  • Tower Research Capital (TRC)'s Guardian Pharmacy Services position peaked at $80.9K in Q2 2026.
  • 197 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.